We only have this paper's title and publication details.
Read it at the sourceantigens and suggests that patients may benefit from immunomodulatory therapies.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: